Adagio Medical (ADGI) Receives Nasdaq Notice for Bid Price Issue
Published on 6/12/2026
AI Summary
Summarized by AI from the source belowAdagio Medical (ADGI) received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement. The company's stock price has remained below the $1 threshold for 30 consecutive trading days. Nasdaq has provided a 180-day compliance period for Adagio to regain compliance. This notice could impact investor sentiment and trading volume as the company works to meet exchange standards.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
Related News
Markets
Unilever (ULVR) Raises Sales Outlook, Hits Highest Since March
Jul 28
Markets
Basic-Fit Stock Surge: Key Insights on Today's Market Movement
Jul 28
Markets
Earnings Parade Ahead; Fed Meeting Impacts Markets This Week
Jul 28
Markets
SIG stock rises with increased investor interest and market activity
Jul 28